Mai A. Mostafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mai A. Mostafa has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Hany M. Hassanin
Department of Chemistry, Faculty of Education, Ain Shams University Roxy
3 shared publications- Al-Shimaa Badran
Department of Chemistry, Faculty of Education, Ain Shams University, Roxy, Cairo 11711, Egypt
2 shared publications Jehan M. Morsy
Department of Chemistry, Faculty of Education, Ain Shams University Roxy, 11711 Cairo, Egypt
2 shared publications- Magdy Ahmed Ibrahim
Department of Chemistry, Faculty of Education, Ain Shams University, Roxy, 11711, Cairo, Egypt
2 shared publications Mostafa M. Ismail
Department of Chemistry, Faculty of Education, Ain Shams University Roxy
2 shared publicationsE. E. Bahig
Department of Chemistry, Faculty of Education, Ain Shams University, Roxy, Cairo, Egypt
1 shared publication
Latest Publications
- 17 August 2026
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 46 (8) , 1248-1277
Synthesis and DFT Study of New Pyrano[3,2-c]Quinoline Derivatives for Antioxidant, Forensic, and Security Ink Applications
1. The quinoline skeleton plays a crucial role in enhancing pharmacological activity. Quinoline-based scaffolds have demonstrated notable efficacy as growth inhibitors through the suppression of ce...
- 17 August 2026
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 46 (8) , 1248-1277
Synthesis and DFT Study of New Pyrano[3,2-c]Quinoline Derivatives for Antioxidant, Forensic, and Security Ink Applications
1. The quinoline skeleton plays a crucial role in enhancing pharmacological activity. Quinoline-based scaffolds have demonstrated notable efficacy as growth inhibitors through the suppression of ce...
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Chemistry of 6-alkyl-4-hydroxy-3-substituted-pyrano[3,2- c ]quinoline-2,5(6 H )-diones: a comprehensive review of their synthesis, chemical transformations, and applications (2012–2026)
Synthesis, C-3 functionalization, and chemical transformations of 6-alkyl-4-hydroxy-3-substituted-pyrano[3,2- c ]quinoline-2,5(6 H )-diones, with their biological, optical, electronic, photovoltaic, and corrosion applications.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessChemistry of 6-alkyl-4-hydroxy-3-substituted-pyrano[3,2- c ]quinoline-2,5(6 H )-diones: a comprehensive review of their synthesis, chemical transformations, and applications (2012–2026)
Synthesis, C-3 functionalization, and chemical transformations of 6-alkyl-4-hydroxy-3-substituted-pyrano[3,2- c ]quinoline-2,5(6 H )-diones, with their biological, optical, electronic, photovoltaic, and corrosion applications.
- Open Access
- 26 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (9) , 6718-6736
Synthetic approaches for novel 3-heteroaryl-4-hydroxy-1-methylquinoline-2(1 H )one: spectroscopic characterization, molecular docking and DFT investigations
Ring opening and recyclization reactions with 4-hydroxy-6-methyl-3-nitro-2 H -pyrano[3,2- c ]quinoline-2,5(6 H )-dione (1) was examined towards some carbon nucleophilic reagents.
- 26 February 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (9) , 6718-6736
Open AccessSynthetic approaches for novel 3-heteroaryl-4-hydroxy-1-methylquinoline-2(1 H )one: spectroscopic characterization, molecular docking and DFT investigations
Ring opening and recyclization reactions with 4-hydroxy-6-methyl-3-nitro-2 H -pyrano[3,2- c ]quinoline-2,5(6 H )-dione (1) was examined towards some carbon nucleophilic reagents.
- Open Access
- 18 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (41) , 29919-29933
New synthetic chitosan Schiff bases bearing pyranoquinolinone or benzonaphthyridine and their silver nanoparticles derivatives with potential activity as antioxidant and molecular docking study for EGFR inhibitors
In this study, two new carboxaldehydes 3, and 4 were synthesized by Vilsmeier–Haack formylation of 6-butyl-benzo[h][1,6]naphthyridine-2,5-dione 2 and 6-butyl-pyrano[3,2-c]quinolinone 1, respectively. Structures of newly synthesized compounds were achieved by IR, 1H NMR, 13C NMR, mass techniques, and elemental analyses. The two synthesized carboxaldehydes 3 and 4 were used as precursors for the synthesis of two new chitosan-based Schiff bases, CS1 and CS2. The new chitosan Schiff bases were grafted on silver nanoparticles, providing CS1/Ag and CS2/Ag structures. However, CS1 and CS2 and their silver nanoparticles were characterized by FT-IR, XRD, SEM-EDX, XRF, TEM, TGA, and DSC. The target compounds CS1, CS2, CS1/Ag, and CS2/Ag were assessed as radical scavengers against 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH%). The results showed that CS1 and CS2 had a better ability to scavenge DPPH radical than its unmodified chitosan. CS1/Ag and CS2/Ag, combining the unique properties of silver and Schiff bases, displayed excellent antioxidant activity (IC50, 59.13, and 32.54 μg mL−1, respectively). In addition, the previous compounds were tested in vitro for inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase using the EGFR kinase assay kit (Cat. #40321). In particular, compound CS1/Ag displayed potent inhibitory activity towards EGFR with IC50 20.45 μg mL−1 compared to reference drug sorafenib (IC50 = 0.76 μg mL−1). The bioactivity of new chitosan Schiff bases was studied by molecular docking to see how they bind with the EGFR receptor. The results implied that CS1 has a higher binding energy than CS2 and CS regarding EGFR kinase, which agreed with the results obtained from the experimental EGFR inhibition assay.
- 18 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (41) , 29919-29933
Open AccessNew synthetic chitosan Schiff bases bearing pyranoquinolinone or benzonaphthyridine and their silver nanoparticles derivatives with potential activity as antioxidant and molecular docking study for EGFR inhibitors
In this study, two new carboxaldehydes 3, and 4 were synthesized by Vilsmeier–Haack formylation of 6-butyl-benzo[h][1,6]naphthyridine-2,5-dione 2 and 6-butyl-pyrano[3,2-c]quinolinone 1, respectively. Structures of newly synthesized compounds were achieved by IR, 1H NMR, 13C NMR, mass techniques, and elemental analyses. The two synthesized carboxaldehydes 3 and 4 were used as precursors for the synthesis of two new chitosan-based Schiff bases, CS1 and CS2. The new chitosan Schiff bases were grafted on silver nanoparticles, providing CS1/Ag and CS2/Ag structures. However, CS1 and CS2 and their silver nanoparticles were characterized by FT-IR, XRD, SEM-EDX, XRF, TEM, TGA, and DSC. The target compounds CS1, CS2, CS1/Ag, and CS2/Ag were assessed as radical scavengers against 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH%). The results showed that CS1 and CS2 had a better ability to scavenge DPPH radical than its unmodified chitosan. CS1/Ag and CS2/Ag, combining the unique properties of silver and Schiff bases, displayed excellent antioxidant activity (IC50, 59.13, and 32.54 μg mL−1, respectively). In addition, the previous compounds were tested in vitro for inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase using the EGFR kinase assay kit (Cat. #40321). In particular, compound CS1/Ag displayed potent inhibitory activity towards EGFR with IC50 20.45 μg mL−1 compared to reference drug sorafenib (IC50 = 0.76 μg mL−1). The bioactivity of new chitosan Schiff bases was studied by molecular docking to see how they bind with the EGFR receptor. The results implied that CS1 has a higher binding energy than CS2 and CS regarding EGFR kinase, which agreed with the results obtained from the experimental EGFR inhibition assay.
- 1 June 2024
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 60 (6) , 1086-1106
Synthesis, Reactions, and Biological Activity of Benzo[h][1,6]naphthyridine Derivatives
Benzo[h][1,6]naphthyridine derivatives are imperative synthetic targets that display a variety of interesting biological activities, including anti-Alzheimer, anticancer, antimalarial, and antiparasitic activities. Despite the interesting findings on these compounds, the literature lacks a comprehensive summary of the synthetic methodologies and pharmacological applications of benzo[h][1,6]naphthyridine derivatives. This review deals with recent advances in the benzonaphthyridine chemistry by discussing various synthetic methods utilized for the preparation of benzo[h][1,6]naphthyridine derivatives which possess promising biological properties. It also gives an updated vision of their most common reactions and the utilization of these derivatives as units for several biologically active compounds.
- 1 June 2024
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 60 (6) , 1086-1106
Synthesis, Reactions, and Biological Activity of Benzo[h][1,6]naphthyridine Derivatives
Benzo[h][1,6]naphthyridine derivatives are imperative synthetic targets that display a variety of interesting biological activities, including anti-Alzheimer, anticancer, antimalarial, and antiparasitic activities. Despite the interesting findings on these compounds, the literature lacks a comprehensive summary of the synthetic methodologies and pharmacological applications of benzo[h][1,6]naphthyridine derivatives. This review deals with recent advances in the benzonaphthyridine chemistry by discussing various synthetic methods utilized for the preparation of benzo[h][1,6]naphthyridine derivatives which possess promising biological properties. It also gives an updated vision of their most common reactions and the utilization of these derivatives as units for several biologically active compounds.
- 12 September 2022
- Published by Wiley in Journal of Physical Organic Chemistry
- Vol. 36 (2)
Synthesis, anticancer evaluation, and molecular docking study of novel 4‐hydroxybenzo[h][1,6]naphthyridine‐2,5‐dione derivatives
An operationally efficient and affordable lactone‐to‐lactam transformation was designed from pyrano[3,2‐c]quinolinone 1 to obtain 4‐hydroxybenzo[h][1,6]naphthyridine‐2,5‐dione 2 utilizing ammonium acetate. The newly synthesized compound 2 was subjected to different electrophilic substitution reactions such as nitration, chlorination, bromination, and N‐acylation to obtain novel benzo[h][1,6]naphthyridine derivatives with different substituents at C‐3, C‐4, and NH. Structures of novel products were achieved by elemental analyses and spectroscopic techniques. The benzonapthyridine derivatives were screened for their antitumor activities against some cancer cell lines including HepG‐2, HCT‐116, and MCF‐7. All the examined compounds revealed strong, good, moderate to weak anticancer activity compared with 5‐fluorouracil as a reference standard. Compound (3, ‐3NO2) was the most cytotoxic one and exhibited a higher inhibitory activity than the standard drug against HCT‐116 and MCF‐7 with IC50 values of 20.7 ± 1.9 and 22.5 ± 2.1 μg/ml, respectively, and strong activity against HepG‐2 with IC50 = 15.3 ± 0.7 μg/ml. Moreover, a molecular docking study was carried out for the tested compounds against the crystallographic structure of the Topo II enzyme as a potential target to investigate their binding modes. Docking results showed that compound 6b fitted well into the active site of topoisomerase II (PDB ID: 1ZXM) with hydrogen bond interactions.
- 12 September 2022
- Published by Wiley in Journal of Physical Organic Chemistry
- Vol. 36 (2)
Synthesis, anticancer evaluation, and molecular docking study of novel 4‐hydroxybenzo[h][1,6]naphthyridine‐2,5‐dione derivatives
An operationally efficient and affordable lactone‐to‐lactam transformation was designed from pyrano[3,2‐c]quinolinone 1 to obtain 4‐hydroxybenzo[h][1,6]naphthyridine‐2,5‐dione 2 utilizing ammonium acetate. The newly synthesized compound 2 was subjected to different electrophilic substitution reactions such as nitration, chlorination, bromination, and N‐acylation to obtain novel benzo[h][1,6]naphthyridine derivatives with different substituents at C‐3, C‐4, and NH. Structures of novel products were achieved by elemental analyses and spectroscopic techniques. The benzonapthyridine derivatives were screened for their antitumor activities against some cancer cell lines including HepG‐2, HCT‐116, and MCF‐7. All the examined compounds revealed strong, good, moderate to weak anticancer activity compared with 5‐fluorouracil as a reference standard. Compound (3, ‐3NO2) was the most cytotoxic one and exhibited a higher inhibitory activity than the standard drug against HCT‐116 and MCF‐7 with IC50 values of 20.7 ± 1.9 and 22.5 ± 2.1 μg/ml, respectively, and strong activity against HepG‐2 with IC50 = 15.3 ± 0.7 μg/ml. Moreover, a molecular docking study was carried out for the tested compounds against the crystallographic structure of the Topo II enzyme as a potential target to investigate their binding modes. Docking results showed that compound 6b fitted well into the active site of topoisomerase II (PDB ID: 1ZXM) with hydrogen bond interactions.
- Open Access
- 9 May 2022
- Published by Springer Nature in Polymer Bulletin
- Vol. 80 (4) , 4035-4059
Synthesis, characterization, anticancer, and antioxidant activities of chitosan Schiff bases bearing quinolinone or pyranoquinolinone and their silver nanoparticles derivatives
In this work, new chitosan-based Schiff bases were synthesized by the reaction of chitosan with quinolinone and pyranoquinolinone giving CSQ, and CSP, respectively. The novel Chitosan Schiff bases were grafted on silver nanoparticles providing CSQ/Ag, CSP/Ag structures. Characterization of isolated compounds was carried out by FT-IR, TGA, XRD, SEM, and TEM. The target compounds CSQ, CSP, CSQ/Ag, and CSP/Ag were evaluated as antitumor agents against three cancer cell lines, liver (HepG-2), colon (HCT-116), and breast (MCF-7). Compound CSQ/Ag disclosed potent cytotoxic effect with IC50 values in the range of 41.9–55.1 μg/ml in comparison with 5-fluorouracil against different cancer cell lines. Besides, the antioxidant activity of chitosan and its quinolinone and pyranoquinolinone analogues was assessed as radical scavengers versus 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH%). The compound CSQ/Ag emerged as the most active member in scavenging the DPPH radicals. The obtained findings proved that the new Schiff bases/silver nanoparticles of chitosan showed higher antiproliferative and antioxidant activities than the blank CS and would be highly applicable in biomedical fields. Graphical abstract
- 9 May 2022
- Published by Springer Nature in Polymer Bulletin
- Vol. 80 (4) , 4035-4059
Open AccessSynthesis, characterization, anticancer, and antioxidant activities of chitosan Schiff bases bearing quinolinone or pyranoquinolinone and their silver nanoparticles derivatives
In this work, new chitosan-based Schiff bases were synthesized by the reaction of chitosan with quinolinone and pyranoquinolinone giving CSQ, and CSP, respectively. The novel Chitosan Schiff bases were grafted on silver nanoparticles providing CSQ/Ag, CSP/Ag structures. Characterization of isolated compounds was carried out by FT-IR, TGA, XRD, SEM, and TEM. The target compounds CSQ, CSP, CSQ/Ag, and CSP/Ag were evaluated as antitumor agents against three cancer cell lines, liver (HepG-2), colon (HCT-116), and breast (MCF-7). Compound CSQ/Ag disclosed potent cytotoxic effect with IC50 values in the range of 41.9–55.1 μg/ml in comparison with 5-fluorouracil against different cancer cell lines. Besides, the antioxidant activity of chitosan and its quinolinone and pyranoquinolinone analogues was assessed as radical scavengers versus 1,1-diphenyl-2-picrylhydrazyl radicals (DPPH%). The compound CSQ/Ag emerged as the most active member in scavenging the DPPH radicals. The obtained findings proved that the new Schiff bases/silver nanoparticles of chitosan showed higher antiproliferative and antioxidant activities than the blank CS and would be highly applicable in biomedical fields. Graphical abstract